For other targets including annexin A5 (ANXA5), prothrombin (F2) and renin (REN), there was no firm evidence to link their functions directly to breast cancer progression, and they were less significant in the PPI network, which meant that they might be not important targets for LF triterpenoids. This evidence concerns the gene F2 and breast carcinoma.